CHRISTUS Health Trials New Atrial Fibrillation Treatment

Tyler hospital among first to offer experimental procedure for heart condition.

Apr. 7, 2026 at 1:40am

An extreme close-up X-ray photograph revealing the intricate internal structure of a human heart, with glowing lines tracing the organ's electrical pathways, conceptually illustrating a new procedure to treat atrial fibrillation.A new experimental treatment at CHRISTUS Health aims to disrupt the abnormal electrical signals that cause atrial fibrillation, a common heart rhythm disorder.Tyler Today

The CHRISTUS Health Louis and Peaches Owen Heart Hospital in Tyler, Texas is one of the first medical facilities in the country to offer a new experimental treatment for atrial fibrillation, a common heart rhythm disorder.

Why it matters

Atrial fibrillation affects millions of Americans and can lead to serious complications like stroke if left untreated. This new procedure represents a potential breakthrough in managing the condition, which could improve outcomes for many patients.

The details

The experimental treatment involves a minimally invasive procedure that uses radiofrequency energy to create scar tissue and block abnormal electrical signals in the heart that cause atrial fibrillation. CHRISTUS Health is one of a select group of hospitals participating in clinical trials to evaluate the safety and effectiveness of this new approach.

  • The CHRISTUS Health Louis and Peaches Owen Heart Hospital began offering the experimental atrial fibrillation treatment in April 2026.

The players

CHRISTUS Health

A non-profit Catholic health system that operates hospitals and clinics across Texas, Louisiana, and New Mexico.

Louis and Peaches Owen Heart Hospital

A specialized cardiac care facility in Tyler, Texas that is part of the CHRISTUS Health network.

Got photos? Submit your photos here. ›

What’s next

The clinical trials for the new atrial fibrillation treatment are expected to continue for several more years as researchers gather data on its long-term safety and efficacy.

The takeaway

This innovative procedure represents an important step forward in the treatment of atrial fibrillation, a condition that affects millions. If proven successful, it could provide a new option for patients struggling with this common heart rhythm disorder.